Other languages Avivagen Inc. OTC Markets

Equities

VIVXF

CA05382F2026

Market Closed - OTC Markets Other stock markets 19:49:46 04/06/2024 BST			5-day change	1st Jan Change
0.0036 ^USD	+200.00%		-.--%	+500.00%

2023	Avivagen Inc. Announces New 500 Kg Order for OxC-beta	CI
2023	Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avivagen Inc. Announces New 500 Kg Order for OxC-beta	17/10/23
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29/09/23
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	24/07/23
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	06/06/23
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	25/05/23
Avivagen Announces Review of Strategic Alternatives	17/05/23
Avivagen Inc. Announces Board Changes	19/04/23
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	17/03/23
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	16/03/23
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	21/02/23
Avivagen Inc. Auditor Raises 'Going Concern' Doubt	20/02/23
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	16/09/22
Avivagen anuncia su nuevo cliente de productos lácteos en México	23/08/22
Avivagen Reports New Customer in Mexico; Up 8.6%	19/08/22
Avivagen Inc. Secures New Customer in the Mexican Dairy Industry	19/08/22
Avivagen Inc. Announces Receipt of Repeat Order from Asian Customer	11/08/22
Avivagen Inc. Secures Order for OxC-beta from AB Vista	03/08/22
Avivagen Inc. Announces Sales of Companion Animal Product and 6,000 pouches order through new and existing customers in Taiwan and Mexico	29/07/22
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	15/06/22
Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene	09/06/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Avivagen Inc. OTC Markets

Equities

VIVXF

CA05382F2026

Other languages

Filters